Visby Medical™, a leading innovator in rapid PCR diagnostics, has secured an additional $3.9 million from the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to ...
Testing new antibiotics in India, South Africa or Brazil, where they are needed most, makes scientific sense. But it’ s not without challenges. That's why in India, drug makers like Wockhardt are ...